Insurance companies scrambling to support need for GLP-1 drugs The overwhelming popularity of GLP-1 drugs what President Trump calls the fat shot has insurance companies scrambling to satisfy consumer access to the treatments while at the same time reining in their exorbitant costs
Lancet 394(10193):121130 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF (2017) Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Definition varied across trials
Many of the nutrient-dense foods Price emphasized were animal foods, such as organs, bone broths, liver, and cod liver oil
No liquids, no needles, no temperature sensitivity concerns in normal conditions